Displaying items by tag: Division of Pulmonary, Allergy and Critical Medicine

A UAB researcher suggests that autoimmune disease therapy may be an effective treatment for idiopathic pulmonary fibrosis.
In late March, physicians at the University of Alabama at Birmingham carefully threaded a one-way valve the size of a black-eyed pea into the lower lobe of Dennis Bullock’s left lung. Bullock, a 67-year-old emphysema patient, was the fourth person at UAB to receive the experimental Zephyr® endobronchial valve.
William C. Bailey, professor in the Division of Pulmonary, Allergy and Critical Medicine at the University of Alabama at Birmingham, has been awarded a Lifetime Achievement Award for 50 years of exemplary service by the Tulane Medical Alumni Association.
UAB was part of a promising international study of a combination therapy for patients with the most common cystic fibrosis mutation.
UAB gets $11 million grant for potential groundbreaking study of beta blockers for patients with COPD.
UAB discovery gives better understanding of and potential therapies for septic shock and reperfusion injuries.
UAB is implanting one-way valves in patients with severe emphysema in an effort to reduce their overall lung volume, which improves lung function.
Page 8 of 9